Cite
MLA Citation
Armando R. Irizarry Rovira et al.. “Scientific and Regulatory Policy Committee Points to Consider: Histopathologic Evaluation in Safety Assessment Studies for PEGylated Pharmaceutical Products.” Toxicologic pathology, vol. 46, 2018, pp. 616–635. http://access.bl.uk/ark:/81055/vdc_100073019203.0x00001e